{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreihza4jukj75vm2hl6goltsard4ial72xmz4uinviqr4f4ysjihqa4",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mhvodkt4etl2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreic2we6mvvc4hnnehftvxyx42fcktzhze5pymgkujmcjez676ohjp4"
    },
    "mimeType": "image/jpeg",
    "size": 117566
  },
  "path": "/2026/03/25/denali-therapeutics-hunter-syndrome-rare-disease/?utm_campaign=rss",
  "publishedAt": "2026-03-25T16:19:58.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "biotechnology",
    "drug development",
    "Pharmaceuticals",
    "rare diseases",
    "STAT+"
  ],
  "textContent": "The FDA approved a new medicine from Denali Therapeutics for Hunter syndrome, a notable decision by the agency after a string of rejections of rare disease drugs.",
  "title": "STAT+: FDA approves Denali Therapeutics drug for Hunter syndrome",
  "updatedAt": "2026-03-25T17:59:19.000Z"
}